Page 37 - Read Online

Page 303 Chu et al. J Transl Genet Genom 2022;6:290-303 https://dx.doi.org/10.20517/jtgg.2022.02

9. Armel SR, Volenik A, Demsky R, Malcolmson J, Maganti M, McCuaig J. Setting a baseline: A 7-year review of referral rates and
outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing. Gynecol Oncol 2020;158:440-5.
DOI PubMed
10. Chiang J, Ngeow J. The management of BRCA1 and BRCA2 carriers in Singapore. Chin Clin Oncol 2020;9:62. DOI PubMed
11. Shaw T, Ishak D, Lie D, et al. The influence of Malay cultural beliefs on breast cancer screening and genetic testing: a focus group
study. Psychooncology 2018;27:2855-61. DOI PubMed
12. Steering Committee of Genomic Medicine, Hong Kong Special Administrative Region. Strategic development of genomic medicine in
H o n g K o n g ; 2 0 2 0 . A v a i l a b l e f r o m :
https://www.fhb.gov.hk/download/press_and_publications/otherinfo/200300_genomic/SCGM_report_en.pdf [Last accessed on 9 Jun
2022].
13. Zhao X, Wang P, Tao X, Zhong N. Genetic services and testing in China. J Community Genet 2013;4:379-90. DOI PubMed PMC
14. Hegarty J, Egan SM, Jones MM, et al. The unmet need in cancer genetic services: conducting an environmental scan of the cancer
genetics services in an Irish context underpinned by a mixed methods approach- report prepared for the Irish cancer society, Ireland.
2 0 2 1 . A v a i l a b l e f r o m : h t t p s : / / w w w . c a n c e r . i e / s i t e s / d e f a u l t / f i l e s / 2 0 2 1 -
04/Conducting%20an%20environmental%20scan%20of%20the%20cancer%20genetics%20services%20Report%202021.pdf [Last
accessed on 9 Jun 2022].
15. Truong TK, Kenneson A, Rosen AR, Singh RH. Genetic referral patterns and responses to clinical scenarios: a survey of primary care
providers and clinical geneticists. J Prim Care Community Health 2021;12:21501327211046734. DOI PubMed PMC
16. Yu MWC, Fung JLF, Ng APP, et al. Preparing genomic revolution: attitudes, clinical practice, and training needs in delivering genetic
counseling in primary care in Hong Kong and Shenzhen, China. Mol Genet Genomic Med 2021;9:e1702. DOI PubMed PMC
17. Hospital Authority, Hong Kong Special Administrative Region. Strategic service framework for genetic and genomic services; 2019.
Available from: https://www.ha.org.hk/haho/ho/ap/HAGGSSSF_Eng.pdf [Last accessed on 9 Jun 2022].
18. Census and Statistics Department, Hong Kong Special Administrative Region. Thematic Household Survey Report No. 74.; 2021.
Available from: https://www.censtatd.gov.hk/en/data/stat_report/product/C0000022/att/B11302742021XXXXB0100.pdf [Last
accessed on 9 Jun 2022].
19. Chung CCY, Chan KYK, Hui PW, et al. Cost-effectiveness analysis of chromosomal microarray as a primary test for prenatal
diagnosis in Hong Kong. BMC Pregnancy Childbirth 2020;20:109. DOI PubMed PMC
20. Chu A, Man-Sik Tse D, To Ki Suen D, Kwong A. Baseline knowledge and receptiveness to genetic testing for hereditary breast and
ovarian cancer syndromes in Chinese high-risk females. J Commun Gene 2021.
21. Census and Statistics Department, Hong Kong Special Administrative Region. Hong Kong Population Projections: 2020-2069; 2020.
Available from: https://www.censtatd.gov.hk/en/data/stat_report/product/B1120015/att/B1120015082020XXXXB0100.pdf [Last
accessed on 9 Jun 2022].
22. Census and Statistics Department, Hong Kong Special Administrative Region. 2016 population by-census: summary results; 2017.
Available from: https://www.bycensus2016.gov.hk/data/16bc-summary-results.pdf [Last accessed on 9 Jun 2022].
23. Dheensa S, Samuel G, Lucassen AM, Farsides B. Towards a national genomics medicine service: the challenges facing clinical-
research hybrid practices and the case of the 100 000 genomes project. J Med Ethics 2018;44:397-403. DOI PubMed PMC
24. Consent Clauses for Genomic Research. Consent clauses for genomic research. 2020. Available from:
https://drive.google.com/file/d/1O5Ti7g7QJqS3h0ABm-LyTe02Gtq8wlKM/view [Last accessed on 9 Jun 2022].
25. Global Alliance for Genomics and Health. Global Alliance for genomics and health: consent policy (v2.0); 2019. Available from:
https://www.ga4gh.org/wp-content/uploads/GA4GH-Final-Revised-Consent-Policy_16Sept2019.pdf [Last accessed on 9 Jun 2022].
26. Nguyen MT, Goldblatt J, Isasi R, et al; Model consent clauses for rare disease research.
BMC Med Ethics 2019;20:55. DOI PubMed PMC
27. Genomics England. Consent in the 100,000 genomes project. Available from: https://www.genomicsengland.co.uk/about-genomics-
england/the-100000-genomes-project/information-for-gmc-staff/consent/ [Last accessed on 9 Jun 2022].
28. Rego S, Grove ME, Cho MK, Ormond KE. Informed consent in the genomics era. Cold Spring Harb Perspect Med 2020;10:a036582.
DOI PubMed PMC
29. Robinson PN, Köhler S, Bauer S, Seelow D, Horn D, Mundlos S. The human phenotype ontology: a tool for annotating and analyzing
human hereditary disease. Am J Hum Genet 2008;83:610-5. DOI PubMed PMC
30. Köhler S, Øien NC, Buske OJ, et al. Encoding Clinical data with the human phenotype ontology for computational differential
diagnostics. Curr Protoc Hum Genet 2019;103:e92. DOI PubMed PMC